These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9127690)

  • 1. Non-covalent associations of proteins in plasma: self-, mixed fibrin(ogen), mixed protein-non-protein associations.
    London M
    Clin Biochem; 1997 Mar; 30(2):83-9. PubMed ID: 9127690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of plasminogen-binding sites in human fibrin(ogen).
    Váradi A; Patthy L
    Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could Some Nonhemostatic Plasma Proteins Serve as Refuse Collectors for Fibrin(ogen)?
    Litvinov RI; Weisel JW
    Thromb Haemost; 2019 Dec; 119(12):1900. PubMed ID: 31659735
    [No Abstract]   [Full Text] [Related]  

  • 5. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
    Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
    Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W
    Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of plasmin(ogen) to sepharose bound fibrin(ogen) alpha-chain.
    Cederholm-Williams SA; Fennell SJ
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):503-6. PubMed ID: 6455773
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp(a): an interloper into the fibrinolytic system?
    Miles LA; Plow EF
    Thromb Haemost; 1990 Jun; 63(3):331-5. PubMed ID: 2169655
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator.
    Stief TW; Marx R; Heimburger N
    Thromb Res; 1989 Oct; 56(2):221-8. PubMed ID: 2515607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Force spectroscopy of the fibrin(ogen)-fibrinogen interaction.
    Chtcheglova LA; Haeberli A; Dietler G
    Biopolymers; 2008 Apr; 89(4):292-301. PubMed ID: 18098176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
    Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of human plasminogen to fibrin and fibrinogen.
    Lucas MA; Fretto LJ; McKee PA
    J Biol Chem; 1983 Apr; 258(7):4249-56. PubMed ID: 6833255
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes.
    Cederholm-Williams SA; Swain A
    Thromb Res; 1979; 16(5-6):705-13. PubMed ID: 160626
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of fibrin(ogen) on thrombin generation and decay.
    Kremers RM; Wagenvoord RJ; Hemker HC
    Thromb Haemost; 2014 Sep; 112(3):486-94. PubMed ID: 24964786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.